Newly-Published Study Reinforces Role Of Antiepileptic Drug Vimpat(R) (lacosamide) (C-V) As An Add-on Treatment That Significantly Reduces Epilepsy

March 14th, 2010 | Category: Uncategorized

UCB announced that the antiepileptic drug (AED) Vimpat® (lacosamide) (C-V) demonstrated significantly fewer partial-onset seizures versus placebo in adults living with epilepsy, according to

a Phase III clinical study published online in Epilepsia. This study was one of three that supported the approval of Vimpat by the U.S…

Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Netvouz
  • DZone
  • ThisNext
  • MisterWong
  • Wists
  • Reddit
  • StumbleUpon
  • Technorati
Related Articles
No related posts

No comments yet. Be the first.

Leave a reply